Hansgrohe prototype/shower head: Start of the shower with warm comfort temperature and usual body cleansing. Then the Vital shower is carried out for a total of 3-5 minutes, followed optionally by another warm shower with 30 seconds or direct transition to a classic cold shower for 30- 60 seconds
Study summary
The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.
Eligibility
Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Female and male patients between 18 and 70 years of age
Exclusion Criteria:
* Bad general condition
* Serious acute or chronic comorbidity
* Pregnancy and breast feeding period/ in the next 6 months
* Participation in a clinical trial within the last 3 months before enrollment
* Simultaneous participation in another clinical trial
* Raynaud's disease or cold agglutinin disease
* Severe mental illness
* Insufficiently treated dermatological diseases (e.g. neurodermatitis, psoriasis)
* Non-compatible sanitary shower or bath devices
Primary outcome measure(s)
Immunological laboratory — Change from Baseline and after 4 weeks T-Cells (CD3), B-Cells (CD19), Natural Killer Cells (CD16), T-helper cells (CD4), cytotoxic T-cells (CD8), CD4/CD8 ratio, interleukin 4, interferon gamma
Blood pressure at rest (systolic and diastolic) — Change from Baseline and after 4 weeks
Hospital Anxiety and Depression Scale (HADS-D) — Change from HADS-D Baseline, after 4 weeks and 12 weeks Change
Self-Efficacy Scale (ASKU) — Change from ASKU Baseline, after 4 weeks and 12 weeks Change
WHO-Five Well-Being Index (WHO-5) — Change from WHO-5 Baseline, after 4 weeks and 12 weeks Change
Perceived Stress Scale (PSS-10) — Change from PSS-10 Baseline, after 4 weeks and 12 weeks Change
Flourishing Scale (FS-D) — Change from FS-D Baseline, after 4 weeks and 12 weeks Change
Insomnia Severity Index (ISI-D) — Change from ISI-D Baseline, after 4 weeks and 12 weeks Change
Short Form (SF-36) — Change from SF-36 Baseline, after 4 weeks and 12 weeks Change
Von Zerssen somatic complaint list (B-LR and B-LR') — Change from B-LR and B-LR' Baseline, after 4 weeks and 12 weeks Change
Heart rate variability — Change from Baseline and after 4 weeks Change
Trial sites (1)
Facility
City
Region
Status
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus
Berlin
State of Berlin
Recruiting
More Charite University, Berlin, Germany trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.